Charles Farkas

Charles Farkas (board member) discloses dealings in CONMED Corp to SEC (Form 4). In total, 28 filings cover trades dated from 4 January 2016 to 2 June 2026.

Both buying and selling appear: 10 purchases worth €91k, against 3 sales worth €293k. The net balance comes to €202k on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 2 share grants and 13 option exercises.

The median purchase comes to €9,746. 3 out of 10 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The newest entry dates from 3 June 2026: an option exercise, in CONMED Corp. The clock since the last published purchase (4 January 2018) now reads 3,214 days. Typically, a trade is published a median of 1 day after it takes place. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.